JPRN-C000000320已完成2 期
Validation study of FEC followed by docetaxel as preoperative chemotherapy in primary beast cancer (JBCRG-02') - Validation study of FEC followed by docetaxel as preoperative chemotherapy in primary beast cancer (JBCRG-02')
Japan Breast Cancer Reaserch Group (JBCRG)0 个研究点目标入组 20 人开始时间: 2006年2月2日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 60years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •Hypersensitivity for drugs Serious coexisting illness Active double cancer Bilateral breast cancer Male breast cancer Pregnant or postpartum wemen
研究者
相似试验
进行中（未招募）
不适用
Multicenter phase II study with docetaxel, 5-FU, leucovorin, and oxaliplatin in patients with metastatic or locally advanced gastric cancer or cancer of the esophagogastric junction- FLOTMetastatic or locally advanced gastric cancerEUCTR2005-004135-22-DEKrankenhaus Nordwest42
进行中（未招募）
不适用
Multicenter phase II study evaluating docetaxel, CDDP, and cetuximab as induction regimen prior to surgery in chemonaive patients with NSCLC stage IB, II, and IIIA. - INN06eoadjuvant treatment of non-small lung cancerEUCTR2006-004639-31-ATTAKO
招募中
2 期
DCF+RT for postoperative recurrent esophageal cancerJPRN-jRCTs021200009Jingu Keiichi35
已完成
不适用
Phase I/II study of the combination of docetaxel, CDDP and S-1 in patients with unresectable advanced gastric cancerunresectable advanced gastric cancerJPRN-C000000080Fourth Department of Internal Medicine, Sapporo Medical University40
已完成
2 期
Phase II study of the combination of docetaxel, cisplatin plus S-1(DCS) for advanced or recurrent gastric cancer(KDOG 0601)Gastric cancerJPRN-UMIN000001119Department of Gastroenterology, Kitasato University School of Medicine45